BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan X, Xu S, Li J, Tong N. The Effects of DPP-4 Inhibitors, GLP-1RAs, and SGLT-2/1 Inhibitors on Heart Failure Outcomes in Diabetic Patients With and Without Heart Failure History: Insights From CVOTs and Drug Mechanism. Front Endocrinol (Lausanne) 2020;11:599355. [PMID: 33335511 DOI: 10.3389/fendo.2020.599355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 King A, Rajpura J, Liang Y, Paprocki Y, Uzoigwe C. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease. Curr Med Res Opin 2022;:1-22. [PMID: 36134459 DOI: 10.1080/03007995.2022.2125259] [Reference Citation Analysis]
2 Pan X, Tao S, Tong N. Potential Therapeutic Targeting Neurotransmitter Receptors in Diabetes. Front Endocrinol 2022;13:884549. [DOI: 10.3389/fendo.2022.884549] [Reference Citation Analysis]
3 Salvatore T, Pafundi PC, Galiero R, Albanese G, Di Martino A, Caturano A, Vetrano E, Rinaldi L, Sasso FC. The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms. Front Med (Lausanne) 2021;8:695792. [PMID: 34277669 DOI: 10.3389/fmed.2021.695792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cocchi C, Coppi F, Farinetti A, Mattioli AV. Cardiovascular disease prevention and therapy in women with Type 2 diabetes. Future Cardiol 2021;17:487-96. [PMID: 33739145 DOI: 10.2217/fca-2021-0011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]